Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]

Using bioinformatics and genomics to treat AML

Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany

Using bioinformatics and genomics to treat AML ( Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany )

CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL

Dr Othman Al-Sawaf - Univesity of Cologne, Cologne, Germany

CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL ( Dr Othman Al-Sawaf - Univesity of Cologne, Cologne, Germany )

Cancer care in Latin America

Dr Jean Rene Clemenceau - Hospital Angeles del Pedregal, Mexico City, Mexico

Cancer care in Latin America ( Dr Jean Rene Clemenceau - Hospital Angeles del Pedregal, Mexico City, Mexico )

Implementing better cancer diagnosis in low and middle income countries

Dr Gilberto Lopes - University of Miami and the Miller School of Medicine...

Implementing better cancer diagnosis in low and middle income countries ( Dr Gilberto Lopes - University of Miami and the Miller School of Medicine, Miami, USA )

Project Pink Blue: Fighting cancer through increasing awareness, screening...

Runcie C.W. Chidebe - Executive Director, Project PINK BLUE

Project Pink Blue: Fighting cancer through increasing awareness, screening, advocacy and patient navigation ( Runcie C.W. Chidebe - Executive Director, Project PINK BLUE )

Challenges in global cancer control

Prof Mary Gospodarowicz - University Health Network, Toronto, Canada

Challenges in global cancer control ( Prof Mary Gospodarowicz - University Health Network, Toronto, Canada )

Novel methods of drug testing and biopsy in India

Prof Govind Babu - Kidwai Memorial Institute of Oncology, Bengaluru, India

Novel methods of drug testing and biopsy in India ( Prof Govind Babu - Kidwai Memorial Institute of Oncology, Bengaluru, India )

Inhibition of NADK strongly inhibits T-ALL cells from growing

Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK

Inhibition of NADK strongly inhibits T-ALL cells from growing ( Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK )

CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo...

Dr Jonathan Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA

CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )

Maintenance pembrolizumab vs placebo for metastatic urothelial cancer

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA

Maintenance pembrolizumab vs placebo for metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )

NILE: Should we give everything to patients with unresectable locally advanced...

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA

NILE: Should we give everything to patients with unresectable locally advanced or metastatic urothelial cancer? ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )

CheckMate-142: Updated data from MSI high metastatic colon cancer patients

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

CheckMate-142: Updated data from MSI high metastatic colon cancer patients ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

More from ecancer